Clinical Trial Update: Effects of Imatinib Mesylate in Polycythemia Vera [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating imatinib mesylate in polycythemia vera has completed, with results summarized in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Niguarda Hospital | Conditions: Polycythemia Vera | Phase 2 | Status: COMPLETED